CROMSOURCE announced the appointment of its Regulatory Services Department Director, Mr. David R. Dills, and the expansion of its Regulatory Services portfolio.

Mr. Dills has more than 28 years of experience in the medical device and pharmaceutical industry. He has held positions of increasing responsibility with sponsor and service companies of various sizes, including large, global OEM’s/sponsors, consultancies and a global CROs, as well as virtual, small, mid and large-sized enterprises and has serviced sponsors and clients in multiple global locations.

“Whatever the stage of clinical development, our clients need a partner that can provide the global regulatory capabilities to support their product portfolio for commercial success,” said Dr. Margherita Mosconi, chief services officer. “His tremendous broad experience will support CROMSOURCE in expanding its services into strategic regulatory consultation to biotechnology Companies.”

Like CROMSOURCE, David can call on the wider scientific, medical and regulatory external expert network in specialized areas. Furthermore, the well-established connections with key regulatory experts permit CROMSOURCE to identify the best and defensible regulatory strategy for our clients.

Mr. Dills said, “I do look forward to being part of the CROMSOURCE team and contributing to the company’s ongoing and continuous success in the global marketplace and to be able to further support the increasingly complex product development needs of our global clients. We will offer and expand global regulatory services.”